Acura Pharmaceuticals, Inc. ACUR
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -81.95% | -83.91% | -70.17% | ||
| Total Receivables | -41.37% | 31.52% | 806.80% | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 3.35% | -49.09% | 12.00% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -47.94% | -32.53% | -0.65% | ||
|
|
|||||
| Total Current Assets | -47.94% | -32.53% | -0.65% | ||
| Net Property, Plant & Equipment | 2.01% | 3.13% | -9.90% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -32.05% | -29.41% | -27.47% | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | -36.06% | -25.24% | -4.29% | ||
|
|
|||||
| Total Accounts Payable | -52.46% | 45.39% | -39.81% | ||
| Total Accrued Expenses | 6.93% | -38.76% | 49.69% | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -79.88% | -96.78% | 2.73% | ||
| Total Finance Division Other Current Liabilities | 156.25% | 133.33% | -- | ||
| Total Other Current Liabilities | 156.25% | 133.33% | -- | ||
| Total Current Liabilities | -17.30% | -84.95% | 5.13% | ||
|
|
|||||
| Total Current Liabilities | -17.30% | -84.95% | 5.13% | ||
| Long-Term Debt | -95.64% | 148.99% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -- | -- | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -83.82% | -79.88% | 10.21% | ||
|
|
|||||
| Common Stock & APIC | 1.81% | 1.81% | 0.01% | ||
| Retained Earnings | -0.30% | -0.40% | -0.22% | ||
| Treasury Stock & Other | -- | -- | -- | ||
| Total Common Equity | 102.39% | 107.66% | -15.68% | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | 102.39% | 107.66% | -15.68% | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 102.39% | 107.66% | -15.68% | ||
|
|
|||||